BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22892990)

  • 1. The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome.
    Eikmans M; de Canck I; van der Pol P; Baan CC; Haasnoot GW; Mallat MJ; Vergunst M; de Meester E; Roodnat JI; Anholts JD; van Thielen M; Doxiadis II; de Fijter JW; van der Linden PJ; van Beelen E; van Kooten C; Kal-van Gestel JA; Peeters AM; Weimar W; Roelen DL; Rossau R; Claas FH
    Transplantation; 2012 Sep; 94(5):478-85. PubMed ID: 22892990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients.
    Qiu XY; Jiao Z; Zhang M; Chen JP; Shi XJ; Zhong MK
    Nephrology (Carlton); 2012 May; 17(4):423-30. PubMed ID: 22239151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.
    Damman J; Kok JL; Snieder H; Leuvenink HG; van Goor H; Hillebrands JL; van Dijk MC; Hepkema BG; Reznichenko A; van den Born J; de Borst MH; Bakker SJ; Navis GJ; Ploeg RJ; Seelen MA
    Mol Immunol; 2012 Feb; 50(1-2):1-8. PubMed ID: 22173059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation.
    de Rooij BJ; van der Beek MT; van Hoek B; Vossen AC; Rogier Ten Hove W; Roos A; Schaapherder AF; Porte RJ; van der Reijden JJ; Coenraad MJ; Hommes DW; Verspaget HW
    J Hepatol; 2011 Oct; 55(4):800-7. PubMed ID: 21334396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients.
    Smedbråten YV; Sagedal S; Mjøen G; Hartmann A; Fagerland MW; Rollag H; Mollnes TE; Thiel S
    Transplantation; 2015 Apr; 99(4):791-6. PubMed ID: 25222012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.
    Rekers NV; Flaig TM; Mallat MJK; Spruyt-Gerritse MJ; Zandbergen M; Anholts JDH; Bajema IM; Clahsen-van Groningen MC; Yang J; de Fijter JW; Claas FHJ; Brakemeier S; Lachmann N; Kreutz R; de Heer E; Budde K; Bolbrinker J; Eikmans M
    Transplantation; 2017 Sep; 101(9):2017-2025. PubMed ID: 27926596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative polymerase chain reaction profiling of immunomarkers in rejecting kidney allografts for predicting response to steroid treatment.
    Rekers NV; Bajema IM; Mallat MJ; Zuidwijk K; Anholts JD; Goemaere N; Haasnoot GW; van Groningen MC; van Kooten C; de Fijter JW; Claas FH; Eikmans M
    Transplantation; 2012 Sep; 94(6):596-602. PubMed ID: 22902790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
    Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
    Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
    Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
    Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-recipient age difference and graft survival in living donor kidney transplantation.
    Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
    Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation.
    Krichen H; Gorgi Y; Dhaouadi T; Mecheri Y; Sfar I; Bardi R; Bacha MM; Abderrahim E; Jendoubi-Ayed S; Ayed K; Ben Abdallah T
    Transplant Proc; 2013; 45(10):3472-7. PubMed ID: 24314935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome.
    Tullius SG; Tran H; Guleria I; Malek SK; Tilney NL; Milford E
    Ann Surg; 2010 Oct; 252(4):662-74. PubMed ID: 20881773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
    Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
    Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
    Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M; Kal-van Gestel JA; Haase-Kromwijk BJ; Claas FH; Weimar W;
    Clin Transpl; 2011; ():287-90. PubMed ID: 22755421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does donor kidney to recipient body weight ratio influence long-term outcomes of living-donor kidney transplantation?
    Hwang JK; Kim YK; Kim SD; Park SC; Choi BS; Kim JI; Yang CW; Kim YS; Moon IS
    Transplant Proc; 2012 Jan; 44(1):276-80. PubMed ID: 22310632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.
    Palmer SM; Burch LH; Mir S; Smith SR; Kuo PC; Herczyk WF; Reinsmoen NL; Schwartz DA
    Clin Transplant; 2006; 20(1):30-6. PubMed ID: 16556150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.
    Breulmann B; Bantis C; Siekierka M; Blume C; Aker S; Kuhr N; Grabensee B; Ivens K
    Clin Transplant; 2007; 21(5):615-21. PubMed ID: 17845635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.